Company Overview
- Headquarters
- 1140 O’Brien Drive, Menlo Park CA
- Website
- recodetx.com
- Phone
- (408) 585-1700
- Employees
- 117
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is ReCode Therapeutics
ReCode Therapeutics is a clinical-stage company based in Menlo Park, California. The company employs 117 people. ReCode Therapeutics specializes in developing genetic medicines, specifically focusing on mRNA and gene correction therapeutics. Their proprietary technology, called selective organ targeting (SORT) lipid nanoparticle (LNP) platform, aims to deliver genetic medicines precisely to target organs and cells, going beyond the traditional limitations of liver-focused delivery. The company's unique SORT platform sets it apart in the genetic medicines field, offering a more precise and potentially effective approach to treating a wider range of diseases. For more information about ReCode Therapeutics and its innovative genetic medicine solutions, please visit their website at recodetx.com.
Company Leadership
Companies Similar to ReCode Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to ReCode Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |